Concord Biotech Ltd
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 |
|---|---|---|---|
| Revenue | 322.77 | 273.61 | 341.43 |
| Operating Expense | 202.50 | 173.34 | 203.51 |
| Net Profit | 75.71 | 61.19 | 90.02 |
| Net Profit Margin | 23.46% | 22.36% | 26.37% |
| Earning Per Share | 7.24 | 5.85 | 8.60 |
| EBIDTA | 119.04 | 99.63 | 138.22 |
| Effective Tax Rate | 20.77% | 20.32% | 20.77% |
Particulars
Sep 2026
Revenue322.77
Operating Expense202.50
Net Profit75.71
Net Profit Margin23.46
Earning Per Share7.24
EBIDTA119.04
Effective Tax Rate20.77
